No specific case,- my question was stemming from a lecture we had on OM and how one of the differentials is charcot. I just figured a bone biopsy might be contraindicated if you knew the patient had poor wound healing, poor/no pulse, high HbA1c.
Thanks for the thorough responses
If there is no break in the dermal envelope (ulcer) or history of such, the likelihood of OM is extremely low and can almost be ruled out on clinical grounds.
The most complex cases have an ulcer and radiographic changes in the bone near the ulcer. In these cases it can be Charcot, OM, or both. MRI is not a good tool to distinguish Charcot from OM. If you are using an MRI, you need to consider "secondary signs". 1. OM usually affects only 1 bone, Charcot a joint or several joints. 2. OM usually affects the forefoot or calcaneus, Charcot the midfoot or ankle. 3. OM usually has a visible tract on MRI from the skin to the bone.
Another good way to determine Charcot from OM, is by using combination bone scans. Tech99 and In111 or Ceretec. Tech99 and Ceretec can't be done on the same day, but Ceretec is a better WBC scan than In111.
We have been using PET scan as a single test to differentiate Charcot from OM. There are a few articles on this from Germany. So far, we've found the SUV is able to differentiate based on uptake.
I wrote an article on this topic which we review all the imaging tests and their sensitivities/specificities for Charcot: Imaging of the Charcot Foot. Clin Podiatr Med Surg 2008;25:263-274
Bone biopsy is fine, but can get contaminated, and should be done under fluoro.
In summary, it is a combination of clinical exam and imaging tests that provide the most accurate results.